Weekly report of commercial trade industry: akabang’s net profit turned from loss to profit year-on-year, and the first zebrafish detection cosmetics was filed

Review of sector Market:

This week (2.7 ~ 2.13), Shenwan beauty care sector decreased by – 1.48%, weaker than the market. Shanghai Composite Index and gem index were + 3.02% and – 5.59% respectively. Shenwan beauty care sector lost 4.50pct to Shanghai Composite Index and outperformed gem index by 4.11pct.

Wind medical beauty and cosmetics index: this week, CSI 300 index + 0.82%, wind medical beauty index + 0.68%, underperforming CSI 300 market by 0.14pct; The wind cosmetics index was – 0.25%, underperforming the CSI 300 market by 1.07pct.

Industry highlights:

The first cosmetics with efficacy claim evaluation by Huante biological zebrafish detection technology has been successfully filed through the cosmetics filing system of the State Food and drug administration. It has become the first cosmetics with successful efficacy filing by using zebrafish detection report under the new regulations of cosmetics in China, opening a precedent for the application of zebrafish biological detection in cosmetics efficacy filing in China. (AP).

Company announcement:

Lancy Co.Ltd(002612) : akabang, its overseas holding subsidiary, issued a performance forecast for 2021. It is expected to achieve an operating revenue of 850 million yuan, a year-on-year increase of 18%, and a net profit of 72.463 million yuan, a year-on-year increase of 729%.

Nanjing Cosmos Chemical Co.Ltd(300856) : Anqing Kosi, a wholly-owned subsidiary of the company, obtained the use right of state-owned construction land with the number of qingzizizi (2021) 067 through bidding, and signed the transfer contract of use right of state-owned construction land with anqing natural resources and Planning Bureau.

Investment advice

(1) cosmetics industry: the supervision of all links in the cosmetics industry has been tightened, and the product quality has attracted more and more attention. In terms of channels, online traffic changes, and the shaking platform has gradually become a new beauty position. Strong products + strong brands bring the possibility of breaking the brand circle, and continue to pay attention to the head cosmetics brand with strong R & D ability and brand strength. Focus on: [ Yunnan Botanee Bio-Technology Group Co.Ltd(300957) ] subdivide the leaders in the field of sensitive muscle skin care; [ Proya Cosmetics Co.Ltd(603605) ] diversified high-quality brands; [ Shanghai Jahwa United Co.Ltd(600315) ] multi category development and continuous innovation to create new items; [ Guangdong Marubi Biotechnology Co.Ltd(603983) ] mainly focuses on medium and high-end, with rich marketing and distribution channels; [ Syoung Group Co.Ltd(300740) ] strong operation capacity and gradual improvement of category structure;

(2) medical beauty industry: the demand side of the medical beauty industry continues to expand, the supply side products are more diversified, and the policy side strengthens the supervision of medical beauty institutions and medical beauty products. We are optimistic about upstream medical and American enterprises with class III medical device certificate and perfect product matrix layout and downstream medical institutions with long-term standardized operation. Attention: [ Bloomage Biotechnology Corporation Limited(688363) ] local hyaluronic acid raw material leader; [ Imeik Technology Development Co.Ltd(300896) ] Tongyan needle is heavily listed and differentiated to meet higher demand; [ Huadong Medicine Co.Ltd(000963) ] overall layout of medical and American business; [ Shanghai Haohai Biological Technology Co.Ltd(688366) ] integration of R & D, production and sales; [tetracyclic medicine] botulinum toxin + double antibody go hand in hand; Pay attention to Lancy Co.Ltd(002612) and so on.

Risk tips

The risk of intensified industry competition; Uncertainty of industrial regulatory policies; Macroeconomic fluctuations, etc.

- Advertisment -